Skip to main content

Month: July 2025

Kinross announces sale of shares of White Gold

(All dollar amounts are expressed in Canadian dollars, unless otherwise noted.) TORONTO, July 25, 2025 (GLOBE NEWSWIRE) — Kinross Gold Corporation (“Kinross” or the “Company”) (TSX: K, NYSE: KGC) announced today that it has sold an aggregate of 23,681,160 common shares of White Gold Corp. (“White Gold”) representing all of the common shares held by Kinross. The shares represent approximately 12% of the outstanding White Gold common shares. The shares were sold at an average sales price of $0.29 (excluding commission), representing an aggregate sale price of $6,869,905.51. A copy of the early warning report filed by Kinross in connection with the investment will be available on White Gold’s profile on SEDAR+ at www.sedarplus.ca. Alternatively, you may contact Luke Crosby, Senior Vice President, General Counsel and Corporate Secretary...

Continue reading

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to have publicly filed its financial and operational results for the period ended May 31, 2025. All figures are reported in Canadian dollars. The Company’s full set of unaudited condensed interim consolidated financial statements for the quarter and accompanying management’s discussion and analysis can be accessed by visiting the Company’s website at www.PharmAla.ca and its profile page on SEDAR+ at www.sedarplus.ca. “The re-opening of PharmAla’s domestic Canadian distribution has allowed us to execute as much volume in Q2 and Q3 as we did...

Continue reading

Eshallgo Inc. Announced Receipt of Notice from Nasdaq regarding Listing Rule 5550(a)(2).

New York, July 25, 2025 (GLOBE NEWSWIRE) — Shanghai, China July 25, 2025 – Eshallgo, Inc. (NASDAQ:EHGO) (“Eshallgo” or the “Company”) today announced that on July 23, 2025, the Company received a notice from the staff of the Nasdaq Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that for the last 30 consecutive business days, the closing bid price of the Company’s class A ordinary shares was below the minimum bid price of US$1.00 per share requirement set forth in Nasdaq Listing Rule 5550(a)(2). The Nasdaq notification letter has no current effect on the listing or trading of the Company’s class A ordinary shares on Nasdaq.  Pursuant to the Nasdaq Listing Rule 5810(c)(3)(A), the Company is provided with a compliance period of 180 calendar...

Continue reading

ECN Capital Schedules Q2-2025 Conference Call

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) — ECN Capital Corp. (TSX: ECN) (“ECN Capital” or “the Company”) announced today that it intends to file its financial statements and management discussion and analysis for the three-month period ended June 30, 2025, after markets close on Thursday, August 7, 2025. The Company will host an analyst briefing to discuss these results commencing at 5:30 PM (ET) on Thursday, August 7, 2025. The call can be accessed as follows:Webcast https://app.webinar.net/pNznM6Eme5L   Toll-free dial in North America  1-888-304-1803International     1-848-488-9277     Presentation slides http://ecncapitalcorp.com/investors/presentations   A telephone replay of the conference call may also be accessed until September 8, 2025, by dialing 1-800-645-7964 and entering the passcode 5036#. About...

Continue reading

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis on August 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) — Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, announced today that it will effect a reverse stock split of its outstanding shares of common stock at a ratio of 1-for-12 (the “Reverse Stock Split”). The Company’s common stock is expected to commence trading on a split-adjusted basis when the NYSE American market opens on August 5, 2025 under the existing symbol of “CLDI.” The new CUSIP number for the Company’s common stock following the Reverse Stock Split will be 320703 408. The noncompulsory decision to implement this stock split reflects the Company’s aim to optimize market dynamics, broaden...

Continue reading

Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025

DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) — Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands, with a portfolio of novel multi-targeted therapies for use as monotherapy and in combination, today reported its financial results for the fiscal year ended March 31, 2025. Financial Results from Year Ended March 31, 2025 The Company incurred a net loss of approximately $6.8 million during the fiscal year ended March 31, 2025 (“Fiscal 2025”), which includes approximately $0.2 million of net non-cash expenses. This compares to a net loss of approximately $75.4 million during the fiscal year ended March 31, 2024 (“Fiscal 2024”), which included approximately $60.9 million of net non-cash expenses. Net loss decreased by approximately...

Continue reading

VCI Global Launches SecureGPU™ – First Encrypted AI Compute Server for Sovereign and Defense Applications

SecureGPU™ Marks Milestone in Zero-Trust AI Infrastructure; Now Piloting Across Southeast Asia KUALA LUMPUR, Malaysia, July 25, 2025 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ: VCIG) (“VCI Global” or the “Company”), a diversified global holding company with a strategic focus on AI & Robotics, Fintech, Cybersecurity, Capital Market Consultancy, today announced the launch of SecureGPU™, a next-generation encrypted AI compute server developed by its cybersecurity and infrastructure subsidiary, V Gallant Sdn Bhd (“V-Gallant”). SecureGPU™ is the first known server platform integrating GPU compute with real-time PCIe-level encryption, purpose-built for sovereign, defense, and regulated enterprise use. Designed to operate entirely within zero-trust, air-gapped environments, the server enables secure training...

Continue reading

Hubbell Incorporated Reports Regular Quarterly Dividend

Shelton, CT, July 25, 2025 (GLOBE NEWSWIRE) — The Board of Directors of Hubbell Incorporated (NYSE:HUBB) today declared a regular quarterly dividend of $1.32 per share on the Company’s common stock. The dividend will be paid September 15, 2025 to shareholders of record on August 29, 2025.  Hubbell Incorporated is a leading manufacturer of utility and electrical solutions enabling customers to operate critical infrastructure reliably and efficiently. With 2024 revenues of $5.6 billion, Hubbell solutions energize economies and electrify communities in front of and behind the meter. The corporate headquarters is located in Shelton, CT. Contact:     Dan Innamorato                   Hubbell Incorporated                   40 Waterview Drive                   P.O Box 1000                   Shelton, CT 06484

Continue reading

JAKKS Pacific Reveals All-New SUPER MARIO, THE SIMPSONS, DC X SONIC THE HEDGEHOG, BENDY and DOG MAN Toys and Collectibles at San Diego Comic-Con 2025

SANTA MONICA, Calif., July 25, 2025 (GLOBE NEWSWIRE) — JAKKS Pacific, Inc. (NASDAQ: JAKK) today, during a special panel at San Diego Comic-Con unveiled an all-new dynamic lineup inspired by iconic franchises including Super Mario, The Simpsons, DC x Sonic the Hedgehog, Bendy, and Dog Man. The crowd went wild with excitement for the Super Mario Big Bad Bowser, a towering 12-inch tall figure with sound effects, “fire breathing” light feature and slashing arms, storming exclusively into Costco this fall. Yours Truly, Princess Peach with her iconic floaty jump pose and 25+ quotes, sounds, and music made her a huge hit. Fans of The Simpsons lit up at the reveal of the Treehouse of Horror Countdown Advent Calendar, packed with 31 days of spooky mystery characters and accessories, as well as two all-new 5-inch Premium Figures, the monstrous...

Continue reading

KPN completes € 250m share buyback

Today, KPN announces the completion of its € 250m share buyback, which commenced on 25 February 2025 and was completed on 25 July 2025. In total, KPN has repurchased 62,465,117 ordinary shares at an average price of € 4.00 per share. The share buyback reflects KPN’s commitment to structurally returning additional capital to its shareholders and was executed by an intermediary on behalf of KPN. KPN intends to cancel 61,465,117 of the repurchased shares to reduce its capital. The remaining 1,000,000 repurchased shares will be retained to cover employee share plans. For the weekly transaction update, KPN reports that it has repurchased 5,294,379 ordinary shares in the period from 21 July 2025 to 25 July 2025, which were the final days of the € 250m share buyback. These shares were repurchased at an average price of € 3.99 per share...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.